VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique, sourcing promising life science innovations directly from universities nationwide. It provides funding to launch startup companies and advance these technologies, ultimately...

VIC Tech 2025 Mid-Year Update

VIC Tech achieved key milestones in H1 2025, including portfolio advancements, strategic partnerships, and talent development. We remain focused on FDA submissions, clinical trials, and scaling initiatives to drive...

VIC Tech Expands Strategic Advisory Board with Addition of MedTech Innovator and Gastroenterology Expert Virender “VK” Sharma, MD

VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Virender “VK” Sharma, MD, to its Strategic Advisory Board (SAB). A recognized...

Market Access for Medical Devices in Europe: England, France, Germany, Italy, and Spain

Introduction VIC Technology Venture Development is pleased to introduce the first installment in a new educational series on international market access for life science innovations. This white paper, developed by our...

Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation

In an industry where advanced degrees and technical titles often take center stage, Laura Lyons brings something just as powerful to the table; lived experience, heart, and a relentless drive to make life better for...

Enhance Diagnostics Granted FDA Breakthrough Device Designation

Fayetteville, AR – July 8, 2025 – Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...

Nob Hill Therapeutics Expands Strategic Advisory Board with Two Distinguished Leaders in Respiratory Drug Development and Pulmonary Medicine

Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announcethe addition of two prominent experts to its Strategic Advisory Board: Dr. Mark Parry-Billings, a seasoned biotech and pharmaceutical executive with...

VIC Fellows Spotlight: Dhananjay Tambe, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

Cellia Science Awarded $2M NIH SBIR Phase II Grant for Real-Time Bone Marrow Adequacy Assessment

Cellia Science announced today it has been awarded a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National...

Five Years of Impact: The VIC Fellows Program and the Future of Life Science Innovation

Launched in 2019, the VIC Fellows Program was created to harness the talents of individuals from a wide variety of scientific, medical, and commercial backgrounds and immerse them in the dynamic world of life science...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
News
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
Interview
VIC Fellows Spotlight: Karim ReFaey, MD
From The Corner Office
From the Corner Office: Zebra Analytix